| Literature DB >> 25329542 |
Kunzhe Dong1, Na Yao1, Yabin Pu1, Xiaohong He1, Qianjun Zhao1, Yizhao Luan2, Weijun Guan1, Shaoqi Rao2, Yuehui Ma1.
Abstract
High altitude environments are of particular interest in the studies of local adaptation as well as their implications in physiology and clinical medicine in human. Some Chinese pig breeds, such as Tibetan pig (TBP) that is well adapted to the high altitude and Dahe pig (DHP) that dwells at the moderate altitude, provide ideal materials to study local adaptation to altitudes. Yet, it is still short of in-depth analysis and understanding of the genetic adaptation to high altitude in the two pig populations. In this study we conducted a genomic scan for selective sweeps using FST to identify genes showing evidence of local adaptations in TBP and DHP, with Wuzhishan pig (WZSP) as the low-altitude reference. Totally, we identified 12 specific selective genes (CCBE1, F2RL1, AGGF1, ZFPM2, IL2, FGF5, PLA2G4A, ADAMTS9, NRBF2, JMJD1C, VEGFC and ADAM19) for TBP and six (OGG1, FOXM, FLT3, RTEL1, CRELD1 and RHOG) for DHP. In addition, six selective genes (VPS13A, GNA14, GDAP1, PARP8, FGF10 and ADAMTS16) were shared by the two pig breeds. Among these selective genes, three (VEGFC, FGF10 and ADAMTS9) were previously reported to be linked to the local adaptation to high altitudes in pigs, while many others were newly identified by this study. Further bioinformatics analysis demonstrated that majority of these selective signatures have some biological functions relevant to the altitude adaptation, for examples, response to hypoxia, development of blood vessels, DNA repair and several hematological involvements. These results suggest that the local adaptation to high altitude environments is sophisticated, involving numerous genes and multiple biological processes, and the shared selective signatures by the two pig breeds may provide an effective avenue to identify the common adaptive mechanisms to different altitudes.Entities:
Mesh:
Year: 2014 PMID: 25329542 PMCID: PMC4201535 DOI: 10.1371/journal.pone.0110520
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Principle component analysis of TBP, DHP and WZSP individuals.
TBP, Tibetan pig; DHP, Dahe pig; WZSP, Wuzhishan pig.
Figure 2Distributions of F values in different breed comparisons.
TBP, Tibetan pig; DHP, Dahe pig; WZSP, Wuzhishan pig.
Genomic regions under selection identified in comparison of TBP and WZSP.
| Chr | Region (Mb) | Max | Min | Min | Genes within selected regions |
| 1 | 35.37–35.77 | 0.565 | p<2.64E-07 | 9.34E-03 |
|
| 1 | 42.80–42.83 | 0.604 | p<2.64E-07 | 5.37E-03 | |
| 1 | 70.70–70.82 | 0.714 | p<2.64E-07 | 8.06E-04 | |
| 1 | 77.86–78.30 | 0.750 | p<2.64E-07 | 3.36E-04 | |
| 1 | 178.80–179.00 | 0.721 | p<2.64E-07 | 6.05E-04 |
|
| 1 | 257.07–257.20 | 0.887 | p<2.64E-07 | 0.00E+00 |
|
| 1 | 267.89–268.36 | 0.632 | p<2.64E-07 | 3.36E-03 |
|
| 1 | 278.53–278.64 | 0.632 | p<2.64E-07 | 3.36E-03 | |
| 2 | 87.34–87.73 | 0.628 | p<2.64E-07 | 3.63E-03 |
|
| 2 | 137.74–138.40 | 0.583 | p<2.64E-07 | 7.59E-03 |
|
| 3 | 6.555–6.558 | 0.587 | p<2.64E-07 | 7.12E-03 | |
| 4 | 33.81–34.26 | 0.590 | p<2.64E-07 | 6.85E-03 |
|
| 4 | 65.95–66.09 | 0.566 | p<2.64E-07 | 9.07E-03 | |
| 4 | 66.95–67.20 | 0.717 | p<2.64E-07 | 6.72E-04 |
|
| 4 | 141.58–142.01 | 0.591 | p<2.64E-07 | 6.79E-03 |
|
| 5 | 55.36–55.78 | 0.647 | p<2.64E-07 | 2.69E-03 |
|
| 6 | 109.79–109.86 | 0.625 | p<2.64E-07 | 3.83E-03 |
|
| 7 | 56.15–56.23 | 0.708 | p<2.64E-07 | 1.01E-03 | |
| 7 | 65.80–65.98 | 0.715 | p<2.64E-07 | 7.39E-04 | |
| 7 | 125.9429–125.9430 | 0.645 | p<2.64E-07 | 2.82E-03 | |
| 8 | 27.12–27.49 | 0.569 | p<2.64E-07 | 8.67E-03 | |
| 8 | 57.74–57.75 | 0.589 | p<2.64E-07 | 6.92E-03 | |
| 8 | 91.21–91.35 | 0.703 | p<2.64E-07 | 1.21E-03 |
|
| 8 | 102.21–103.34 | 0.791 | p<2.64E-07 | 1.34E-04 |
|
| 8 | 105.18–105.46 | 0.622 | p<2.64E-07 | 4.37E-03 | |
| 8 | 108.70–109.10 | 0.686 | p<2.64E-07 | 1.48E-03 |
|
| 8 | 146.65–146.73 | 0.650 | p<2.64E-07 | 2.62E-03 |
|
| 9 | 22.97–23.41 | 0.780 | p<2.64E-07 | 2.69E-04 |
|
| 9 | 93.10–93.21 | 0.833 | p<2.64E-07 | 0.00E+00 | |
| 9 | 122.78–123.11 | 0.671 | p<2.64E-07 | 2.02E-03 | |
| 9 | 140.59–140.74 | 0.631 | p<2.64E-07 | 3.36E-03 |
|
| 11 | 2.72–2.87 | 0.618 | p<2.64E-07 | 4.57E-03 |
|
| 11 | 6.14–6.16 | 0.683 | p<2.64E-07 | 1.68E-03 |
|
| 11 | 8.14–8.56 | 0.702 | p<2.64E-07 | 1.34E-03 |
|
| 11 | 68.77–69.16 | 0.671 | p<2.64E-07 | 2.08E-03 | |
| 13 | 46.62–46.65 | 0.686 | p<2.64E-07 | 1.55E-03 | |
| 13 | 50.67–50.69 | 0.721 | p<2.64E-07 | 6.72E-04 |
|
| 13 | 60.17–60.18 | 0.702 | p<2.64E-07 | 1.41E-03 | |
| 13 | 60.98–61.21 | 0.619 | p<2.64E-07 | 4.50E-03 | |
| 13 | 82.47–82.50 | 0.759 | p<2.64E-07 | 3.36E-04 |
|
| 14 | 16.30–16.54 | 0.626 | p<2.64E-07 | 3.83E-03 |
|
| 14 | 44.86–44.98 | 0.613 | p<2.64E-07 | 4.77E-03 |
|
| 14 | 53.16–53.24 | 0.721 | p<2.64E-07 | 6.05E-04 |
|
| 14 | 71.80–72.93 | 0.742 | p<2.64E-07 | 4.03E-04 |
|
| 15 | 44.40–44.86 | 0.691 | p<2.64E-07 | 1.48E-03 |
|
| 15 | 87.54–87.64 | 0.604 | p<2.64E-07 | 5.44E-03 |
|
| 15 | 95.12–95.92 | 0.671 | p<2.64E-07 | 2.08E-03 |
|
| 15 | 150.24–150.37 | 0.626 | p<2.64E-07 | 3.83E-03 |
|
| 16 | 30.26–30.96 | 0.723 | p<2.64E-07 | 6.05E-04 |
|
| 16 | 31.61–31.98 | 0.637 | p<2.64E-07 | 3.29E-03 |
|
| 16 | 68.45–68.47 | 0.623 | p<2.64E-07 | 4.30E-03 |
|
| 16 | 71.35–71.75 | 0.638 | p<2.64E-07 | 3.29E-03 |
|
| 16 | 82.68–82.84 | 0.688 | p<2.64E-07 | 1.48E-03 |
|
Notes: P, permutation p-value, and for comparison of TBP and WZSP, the Bonferroni corrected significant level (at α = 0.01) for P = 0.01/37, 893 (# of SNPs analyzed) = 2.64E-07; P, empirical p-value; Adaptive genes that have plausible biological functions contributing local adaptation are in bold.
Figure 3Genomic F distribution of selective signatures identified in comparison of TBP and WZSP.
Red dots represent significant sites (F≥0.362, and P≤0.01, data not shown) within selected regions containing adaptive genes.
Functional enrichment analysis of genes within the selected regions identified in comparison of TBP and WZSP.
| GO term | GO category | Gene number | p-value | Benjamini |
| GO:0007276 | gamete generation | 7 | 0.008 | 0.998 |
| GO:0048514 | blood vessel morphogenesis | 5 | 0.014 | 0.996 |
| GO:0019953 | sexual reproduction | 7 | 0.016 | 0.984 |
| GO:0048609 | reproductive process in a multicellular organism | 7 | 0.020 | 0.983 |
| GO:0032504 | multicellular organism reproduction | 7 | 0.020 | 0.983 |
| GO:0001568 | blood vessel development | 5 | 0.023 | 0.975 |
| GO:0001944 | vasculature development | 5 | 0.025 | 0.965 |
| GO:0001525 | angiogenesis | 4 | 0.028 | 0.959 |
| GO:0032103 | positive regulation of response to external stimulus | 3 | 0.033 | 0.962 |
| GO:0032101 | regulation of response to external stimulus | 4 | 0.033 | 0.950 |
| GO:0048232 | male gamete generation | 5 | 0.048 | 0.979 |
| GO:0007283 | spermatogenesis | 5 | 0.048 | 0.979 |
Notes: GO term, subcategory of biological process.
Genomic regions under selection identified in comparison of DHP and WZSP.
| Chr | Region (Mb) | Max | Min | Min | Genes within selected regions |
| 1 | 33.72–34.18 | 0.891 | p<3.06E-07 | 7.73E-04 |
|
| 1 | 41.84–41.99 | 0.795 | p<3.06E-07 | 3.94E-03 |
|
| 1 | 65.31–65.32 | 0.798 | p<3.06E-07 | 3.56E-03 | |
| 1 | 77.80–78.50 | 0.912 | p<3.06E-07 | 2.32E-04 | |
| 1 | 91.68–92.00 | 0.891 | p<3.06E-07 | 7.73E-04 |
|
| 1 | 95.87–96.06 | 0.759 | p<3.06E-07 | 5.80E-03 | |
| 1 | 256.78–257.14 | 0.982 | p<3.06E-07 | 0.00E+00 |
|
| 1 | 278.35–278.82 | 0.875 | p<3.06E-07 | 1.00E-03 |
|
| 1 | 297.24–297.27 | 0.776 | p<3.06E-07 | 5.02E-03 |
|
| 2 | 137.19–137.24 | 0.763 | p<3.06E-07 | 5.64E-03 |
|
| 3 | 12.09–12.23 | 0.767 | p<3.06E-07 | 5.49E-03 | |
| 3 | 55.80–56.01 | 0.853 | p<3.06E-07 | 1.62E-03 |
|
| 4 | 17.65–17.65 | 0.768 | p<3.06E-07 | 5.33E-03 | |
| 4 | 57.71–57.84 | 0.912 | p<3.06E-07 | 2.32E-04 |
|
| 4 | 65.95–66.12 | 0.858 | p<3.06E-07 | 1.31E-03 | |
| 4 | 67.06–67.20 | 0.851 | p<3.06E-07 | 1.62E-03 |
|
| 4 | 107.28–107.52 | 0.749 | p<3.06E-07 | 6.57E-03 |
|
| 4 | 126.98–127.07 | 0.789 | p<3.06E-07 | 4.56E-03 | |
| 5 | 68.78–69.69 | 0.896 | p<3.06E-07 | 6.18E-04 |
|
| 5 | 71.82–71.89 | 0.822 | p<3.06E-07 | 2.86E-03 | |
| 5 | 75.58–76.06 | 0.930 | p<3.06E-07 | 1.55E-04 |
|
| 5 | 84.38–84.48 | 0.840 | p<3.06E-07 | 2.01E-03 |
|
| 5 | 86.56–86.77 | 0.785 | p<3.06E-07 | 4.71E-03 |
|
| 6 | 7.64–8.02 | 0.765 | p<3.06E-07 | 5.64E-03 |
|
| 8 | 57.78–58.00 | 0.778 | p<3.06E-07 | 4.87E-03 |
|
| 8 | 107.95–108.12 | 0.776 | p<3.06E-07 | 5.02E-03 |
|
| 8 | 146.73–146.94 | 0.811 | p<3.06E-07 | 3.17E-03 |
|
| 9 | 7.07–7.12 | 0.767 | p<3.06E-07 | 5.49E-03 |
|
| 9 | 21.27–21.68 | 0.832 | p<3.06E-07 | 2.40E-03 | |
| 9 | 22.73–22.99 | 0.850 | p<3.06E-07 | 2.01E-03 |
|
| 9 | 106.49–106.56 | 0.768 | p<3.06E-07 | 5.41E-03 | |
| 9 | 138.75–138.76 | 0.771 | p<3.06E-07 | 5.18E-03 |
|
| 9 | 143.77–144.24 | 0.858 | p<3.06E-07 | 1.31E-03 |
|
| 11 | 4.91–5.22 | 0.912 | p<3.06E-07 | 2.32E-04 |
|
| 13 | 73.02–73.29 | 0.844 | p<3.06E-07 | 2.01E-03 |
|
| 13 | 210.65–210.84 | 0.734 | p<3.06E-07 | 7.57E-03 |
|
| 14 | 28.19–28.55 | 0.851 | p<3.06E-07 | 1.86E-03 |
|
| 14 | 118.40–118.81 | 0.803 | p<3.06E-07 | 3.32E-03 |
|
| 16 | 30.26–30.52 | 0.982 | p<3.06E-07 | 0.00E+00 |
|
| 16 | 31.98–32.18 | 0.830 | p<3.06E-07 | 2.47E-03 |
|
| 16 | 82.43–83.81 | 0.891 | p<3.06E-07 | 7.73E-04 |
|
| 17 | 41.27–41.59 | 0.813 | p<3.06E-07 | 3.09E-03 |
|
Notes: P, permutation p-value, and for comparison of DHP and WZSP, the Bonferroni corrected significant level (at α = 0.01) for P = 0.01/32, 729 (# of SNPs analyzed) = 3.06E-07; P, empirical p-value; Adaptive genes that have plausible biological functions contributing local adaptation are in bold.
Figure 4Genomic distribution of signatures of selection identified in comparison of DHP and WZSP.
Red dots represent significant sites (F≥0.450, and P≤0.01, data not shown) within selected regions containing adaptive genes.
Functional enrichment analysis of genes within selected regions identified in comparison of DHP and WZSP.
| GO term | GO category | Gene number | p-value | Benjamini |
| GO:0006144 | purine base metabolic process | 3 | 0.002 | 0.780 |
| GO:0016568 | chromatin modification | 7 | 0.003 | 0.630 |
| GO:0006325 | chromatin organization | 8 | 0.004 | 0.536 |
| GO:0051276 | chromosome organization | 9 | 0.004 | 0.453 |
| GO:0009112 | nucleobase metabolic process | 3 | 0.006 | 0.559 |
| GO:0008284 | positive regulation of cell proliferation | 7 | 0.021 | 0.899 |
| GO:0042127 | regulation of cell proliferation | 10 | 0.021 | 0.861 |
| GO:0016569 | covalent chromatin modification | 4 | 0.029 | 0.900 |
| GO:0001708 | cell fate specification | 3 | 0.029 | 0.879 |
| GO:0046040 | IMP metabolic process | 2 | 0.031 | 0.867 |
| GO:0006189 | ‘de novo’ IMP biosynthetic process | 2 | 0.031 | 0.867 |
| GO:0006188 | IMP biosynthetic process | 2 | 0.031 | 0.867 |
| GO:0031503 | protein complex localization | 2 | 0.036 | 0.882 |
| GO:0009113 | purine base biosynthetic process | 2 | 0.046 | 0.919 |
Notes: GO term, subcategory of biological process.
Summary of shared selective sweeps.
| Overlapping regions (Mb) | SNPs in regions | Position (bp) |
| Promising genes in regions | |
| TBP vs WZSP | DHP vs WZSP | ||||
| Chr1: 257.07–257.14 | INRA0006383 | 257072211 | 0.887 | 0.982 |
|
| H3GA0003822 | 257096974 | 0.612 | 0.611 | ||
| ASGA0006012 | 257136966 | 0.530 | 0.844 | ||
| H3GA0003828 | 257175271 | 0.685 | 0.709 | ||
| ASGA0006016 | 257198514 | 0.598 | 0.693 | ||
| Chr4: 67.05–67.20 | INRA0014374 | 67057104 | 0.556 | 0.851 |
|
| ALGA0025367 | 67199718 | 0.563 | 0.770 | ||
| Chr16: 30.26–30.52 | DRGA0016021 | 30264193 | 0.723 | 0.896 |
|
| MARC0105115 | 30377127 | 0.505 | 0.982 | ||
| DRGA0016027 | 30515922 | 0.568 | 0.909 | ||
| Chr16: 31.98–31.98 | ALGA0090039 | 31983325 | 0.637 | 0.830 |
|
| Chr16: 82.68–82.84 | M1GA0021378 | 82675301 | 0.641 | 0.220 |
|
| ALGA0092291 | 82835496 | 0.688 | 0.042 | ||